Tag Archives: Disinvestment
Disinvestment in health care: friend or foe?
The clinical trial that led Commercial Eyes Market Access Consultant, Bridie Murphy, into the world of health technology assessment is still in the spotlight five years on. In July, The Conversation featured an article that looked at this and other … Continue reading
Posted in Clinical Development, Commercial Eyes, Life Sciences Industry, Market Access, MSAC
Tagged Disinvestment, Health Technology, Pricing, Reimbursement
Comments Off on Disinvestment in health care: friend or foe?
